Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device
Cognoa’s Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. Members of Health Transformation Alliance can now add Canvas Dx to their benefit plans.
Information Courtesy By: Marissa Plescia, #HealthcareNews #Healthcare | Feeds
Cognoa’s Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. Members of Health Transformation Alliance can now add Canvas Dx to their benefit plans.
Click For More Details
2023-02-17 00:39
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.